• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促甲状腺素分泌型垂体腺瘤与格雷夫斯病的罕见并存

A Rare Coexistence of Thyrotropin-Secreting Pituitary Adenoma and Graves Disease.

作者信息

Oda Yuichi, Amano Kosaku, Seki Yasufumi, Watanabe Daisuke, Ichihara Atsuhiro, Kawamata Takakazu

机构信息

Department of Neurosurgery, Tokyo Women's Medical University, Shinjuku-ku, Tokyo 162-8666, Japan.

Department of Medicine, Division of Hormonal Medicine and Bioregulatory Science, Tokyo Women's Medical University, Shinjuku-ku, Tokyo 162-8666, Japan.

出版信息

JCEM Case Rep. 2025 Jul 31;3(9):luaf173. doi: 10.1210/jcemcr/luaf173. eCollection 2025 Sep.

DOI:10.1210/jcemcr/luaf173
PMID:40746500
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12311426/
Abstract

The coexistence of Graves disease (GD) and a thyroid-stimulating hormone (TSH)-secreting pituitary adenoma (TSHoma) is a rare and diagnostically challenging condition. In general, GD typically manifests with low TSH because of excess thyroid hormone production; contrastingly, a TSHoma causes secondary hyperthyroidism with normal or elevated TSH levels. This unusual overlap poses diagnostic and therapeutic challenges; therefore, a careful approach is required to distinguish and manage both conditions. We present the case of a 51-year-old woman with symptoms of hyperthyroidism, elevated thyroid hormones, low TSH, and positive anti-TSH receptor antibodies, which were suggestive of GD 10 years prior. After stopping thiamazole and levothyroxine because of the favorable control of thyroid function 6 months prior, the patient presented a syndrome of inappropriate secretion of TSH and magnetic resonance imaging revealed a pituitary macroadenoma; accordingly, she was diagnosed with concurrent GD and a TSHoma. Treatment involved transsphenoidal resection of the TSHoma and antithyroid medication to control GD. This case illustrates the rarity of coexisting GD and TSHoma and the diagnostic and therapeutic complexities of managing dual hyperthyroidism etiologies. Biochemical testing, antibody assessment, and imaging examination are essential for accurate and early diagnosis of the condition.

摘要

格雷夫斯病(GD)与分泌促甲状腺激素(TSH)的垂体腺瘤(TSH瘤)并存是一种罕见且诊断具有挑战性的情况。一般来说,GD通常因甲状腺激素分泌过多而表现为促甲状腺激素水平降低;相反,TSH瘤导致继发性甲状腺功能亢进,促甲状腺激素水平正常或升高。这种不寻常的重叠带来了诊断和治疗方面的挑战;因此,需要谨慎处理以区分和管理这两种情况。我们报告一例51岁女性病例,该患者有甲状腺功能亢进症状、甲状腺激素升高、促甲状腺激素降低以及抗促甲状腺激素受体抗体阳性,这些表现提示10年前患有GD。在6个月前因甲状腺功能得到良好控制而停用甲巯咪唑和左甲状腺素后,患者出现促甲状腺激素分泌异常综合征,磁共振成像显示垂体大腺瘤;因此,她被诊断为同时患有GD和TSH瘤。治疗包括经蝶窦切除TSH瘤以及使用抗甲状腺药物来控制GD。该病例说明了GD和TSH瘤并存的罕见性以及处理双重甲状腺功能亢进病因时在诊断和治疗上的复杂性。生化检测、抗体评估和影像学检查对于准确、早期诊断该疾病至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/12311426/1e56c2c51ad8/luaf173f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/12311426/3079912450e3/luaf173f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/12311426/5216b88adae7/luaf173f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/12311426/1e56c2c51ad8/luaf173f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/12311426/3079912450e3/luaf173f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/12311426/5216b88adae7/luaf173f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ea/12311426/1e56c2c51ad8/luaf173f3.jpg

相似文献

1
A Rare Coexistence of Thyrotropin-Secreting Pituitary Adenoma and Graves Disease.促甲状腺素分泌型垂体腺瘤与格雷夫斯病的罕见并存
JCEM Case Rep. 2025 Jul 31;3(9):luaf173. doi: 10.1210/jcemcr/luaf173. eCollection 2025 Sep.
2
Concurrent Graves' Disease and TSH Secreting Pituitary Adenoma Presenting Suppressed Thyrotropin Levels: A Case Report and Review of the Literature.同时患有 Graves 病和促甲状腺激素分泌垂体腺瘤,表现为促甲状腺激素水平受抑制:病例报告及文献复习。
Front Endocrinol (Lausanne). 2020 Aug 6;11:523. doi: 10.3389/fendo.2020.00523. eCollection 2020.
3
Effects of lanreotide autogel immediately after a single injection for thyrotropin-producing pituitary tumor.单次注射兰瑞肽凝胶剂后即刻对促甲状腺素垂体瘤的影响
Endocrinol Diabetes Metab Case Rep. 2025 Jun 26;2025(2). doi: 10.1530/EDM-25-0020. Print 2025 Apr 1.
4
Thyroid surgery for Graves' disease and Graves' ophthalmopathy.用于治疗格雷夫斯病和格雷夫斯眼病的甲状腺手术。
Cochrane Database Syst Rev. 2015 Nov 25;2015(11):CD010576. doi: 10.1002/14651858.CD010576.pub2.
5
Screening and subsequent management for thyroid dysfunction pre-pregnancy and during pregnancy for improving maternal and infant health.孕前及孕期甲状腺功能障碍的筛查及后续管理,以改善母婴健康。
Cochrane Database Syst Rev. 2015 Sep 21;2015(9):CD011263. doi: 10.1002/14651858.CD011263.pub2.
6
Unilateral Graves' disease: a case report with concomitant thyroid cancer and systematic review of literature.单侧格雷夫斯病:一例合并甲状腺癌的病例报告及文献系统综述
Minerva Surg. 2025 Jun;80(3):274-281. doi: 10.23736/S2724-5691.25.10685-0. Epub 2025 May 22.
7
Central hyperthyroidism combined with Graves' disease: case series and review of the literature.中枢性甲亢合并 Graves 病:病例系列及文献复习。
Eur Thyroid J. 2023 Jul 28;12(4):e220223. doi: 10.1530/ETJ-22-0223.
8
TSH receptor autoantibody immunoassay in patients with Graves' disease: improvement of diagnostic accuracy over different generations of methods. Systematic review and meta-analysis.促甲状腺激素受体自身抗体免疫测定在 Graves 病患者中的应用:不同代方法对诊断准确性的改善。系统评价和荟萃分析。
Autoimmun Rev. 2012 Dec;12(2):107-13. doi: 10.1016/j.autrev.2012.07.003. Epub 2012 Jul 7.
9
Development of Graves' disease in a patient with lymphocytic hypophysitis following glucocorticoid treatment.糖皮质激素治疗后淋巴细胞性垂体炎患者发生格雷夫斯病。
Endocrinol Diabetes Metab Case Rep. 2025 Jun 25;2025(2). doi: 10.1530/EDM-24-0145. Print 2025 Apr 1.
10
Thyrotropin-producing pituitary adenoma simultaneously existing with Graves' disease: a case report.促甲状腺激素分泌型垂体腺瘤与格雷夫斯病同时存在:一例报告
J Med Case Rep. 2017 Jan 6;11(1):9. doi: 10.1186/s13256-016-1172-4.

本文引用的文献

1
Mixed thyrotropin-secreting pituitary neuroendocrine tumor coexisting with Graves' disease: a case report.混合性促甲状腺素分泌型垂体神经内分泌肿瘤合并格雷夫斯病:一例报告
Front Med (Lausanne). 2024 Sep 4;11:1436400. doi: 10.3389/fmed.2024.1436400. eCollection 2024.
2
Clinical characteristics and outcomes of patients with TSH-secreting pituitary adenoma and Graves' disease - a case report and systematic review.促甲状腺激素分泌型垂体腺瘤合并格雷夫斯病患者的临床特征及预后——病例报告与系统评价
Thyroid Res. 2024 Feb 5;17(1):3. doi: 10.1186/s13044-023-00184-2.
3
Central hyperthyroidism combined with Graves' disease: case series and review of the literature.
中枢性甲亢合并 Graves 病:病例系列及文献复习。
Eur Thyroid J. 2023 Jul 28;12(4):e220223. doi: 10.1530/ETJ-22-0223.
4
Plurihormonal (TSH-GH-prolactin Secreting) PIT-1-Positive pituitary Macroadenoma/Pituitary Neuroendocrine Tumor (PitNET) Associated with Graves' Disease: A Case Report.多激素(TSH-GH-泌乳素分泌)PIT-1 阳性垂体大腺瘤/垂体神经内分泌肿瘤(PitNET)伴 Graves 病:病例报告。
Endocr Metab Immune Disord Drug Targets. 2023;23(12):1557-1561. doi: 10.2174/1871530323666230623161631.
5
Characteristics and response cutoff of octreotide suppression test in thyrotrophin (TSH)-secreting pituitary adenomas.奥曲肽抑制试验在促甲状腺素(TSH)分泌性垂体腺瘤中的特点和反应截止值。
Clin Endocrinol (Oxf). 2023 Sep;99(3):306-314. doi: 10.1111/cen.14921. Epub 2023 Jun 11.
6
Resistance to Thyroid Hormone Beta: A Focused Review.抗甲状腺激素β受体:专题述评。
Front Endocrinol (Lausanne). 2021 Mar 31;12:656551. doi: 10.3389/fendo.2021.656551. eCollection 2021.
7
Preoperative and long-term efficacy and safety of lanreotide autogel in patients with thyrotropin-secreting pituitary adenoma: a multicenter, single-arm, phase 3 study in Japan.促甲状腺激素分泌型垂体腺瘤患者应用兰瑞肽微球的术前和长期疗效及安全性:日本多中心、单臂、3 期研究。
Endocr J. 2021 Jul 28;68(7):791-805. doi: 10.1507/endocrj.EJ20-0707. Epub 2021 Mar 11.
8
A remarkable case of thyrotoxicosis initially caused by graves' disease followed by a probable TSHoma - a case report.一例 Graves 病引起的甲状腺功能亢进症,随后可能是 TSH 瘤——病例报告。
BMC Endocr Disord. 2020 Aug 27;20(1):133. doi: 10.1186/s12902-020-00611-7.
9
Concurrent Graves' Disease and TSH Secreting Pituitary Adenoma Presenting Suppressed Thyrotropin Levels: A Case Report and Review of the Literature.同时患有 Graves 病和促甲状腺激素分泌垂体腺瘤,表现为促甲状腺激素水平受抑制:病例报告及文献复习。
Front Endocrinol (Lausanne). 2020 Aug 6;11:523. doi: 10.3389/fendo.2020.00523. eCollection 2020.
10
Application of indocyanine green fluorescence endoscopic system in transsphenoidal surgery for pituitary tumors.吲哚菁绿荧光内镜系统在经蝶窦垂体瘤手术中的应用。
Acta Neurochir (Wien). 2019 Apr;161(4):695-706. doi: 10.1007/s00701-018-03778-0. Epub 2019 Feb 14.